Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
14.00
+0.37 (2.71%)
May 16, 2025, 10:20 AM - Market open
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $1.67 billion as of May 16, 2025. Its market cap has increased by 64.53% in one year.
Market Cap
1.67B
Enterprise Value
1.54B
1-Year Change
64.53%
Ranking
Category
Stock Price
$14.00
Market Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $1.67B, an increase of 113.39%. That is a compound annual growth rate of 15.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2025 | 1.62B | -0.57% |
| Dec 31, 2024 | 1.63B | 434.82% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | 1.23B | 56.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 658.30B |
| Johnson & Johnson | 359.97B |
| AbbVie | 320.92B |
| Novo Nordisk | 289.00B |
| UnitedHealth Group | 248.87B |
| Abbott Laboratories | 232.01B |
| Novartis AG | 211.47B |
| AstraZeneca | 208.86B |